UPDATE: Mirati Therapeutics (MRTX) PT Raised to $205 at SVB Leerink, Following Strong Combination Data
Tweet Send to a Friend
(Updated - September 21, 2021 8:47 AM EDT)
SVB Leerink analyst Andrew Berens raised the price target on Mirati ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
SVB Leerink analyst Andrew Berens raised the price target on Mirati ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
